Episode Details
Back to Episodes
Imperagen Secures $5M for Enzyme Engineering Revolution
Published 5 days, 22 hours ago
Description
Imperagen, a biotech company, secures £5 million in seed funding to revolutionize enzyme engineering. Utilizing quantum physics simulations and AI, they aim to expedite enzyme development, impacting drug discovery, food production, and biofuels. New CEO Guy Levy-Yurista plans to hire AI experts, enhance R&D, and expand lab capabilities to deliver reliable, sustainable solutions for industries.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/9020c7f70cf7f06c